Skip to main content
British Medical Journal (Clinical Research Ed.) logoLink to British Medical Journal (Clinical Research Ed.)
. 1981 May 9;282(6275):1509–1511. doi: 10.1136/bmj.282.6275.1509

Double-blind randomised controlled trial of folate treatment before conception to prevent recurrence of neural-tube defects.

K M Laurence, N James, M H Miller, G B Tennant, H Campbell
PMCID: PMC1505459  PMID: 6786536

Abstract

A randomized controlled double-blind trial was undertaken in south Wales to prevent the recurrence of neural-tube defects in women who had had one child with a neural-tube defect. Sixty women were allocated before conception to take 4 mg of folic acid a day before and during early pregnancy and 44 complied with these instructions. Fifty-one women were allocated to placebo treatment. There were no recurrences among the compliant mothers but two among the non-compliers and four among the women in the placebo group. Thus there were no recurrences among those who received supplementation and six among those who did not; this difference is significant (p = 0.04). It is concluded that folic acid supplementation might be a cheap, safe, and effective method of primary prevention of neural-tube defects but that this must be confirmed in a large, multicentre trial.

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Hoffbrand A. V., Newcombe F. A., Mollin D. L. Method of assay of red cell folate activity and the value of the assay as a test for folate deficiency. J Clin Pathol. 1966 Jan;19(1):17–28. doi: 10.1136/jcp.19.1.17. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Laurence K. M., Carter C. O., David P. A. Major central nervous system malformations in South Wales. I. Incidence, local variations and geographical factors. Br J Prev Soc Med. 1968 Jul;22(3):146–160. doi: 10.1136/jech.22.3.146. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Laurence K. M., Carter C. O., David P. A. Major central nervous system malformations in South Wales. II. Pregnancy factors, seasonal variation, and social class effects. Br J Prev Soc Med. 1968 Oct;22(4):212–222. doi: 10.1136/jech.22.4.212. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Smithells R. W., Sheppard S., Schorah C. J., Seller M. J., Nevin N. C., Harris R., Read A. P., Fielding D. W. Possible prevention of neural-tube defects by periconceptional vitamin supplementation. Lancet. 1980 Feb 16;1(8164):339–340. doi: 10.1016/s0140-6736(80)90886-7. [DOI] [PubMed] [Google Scholar]
  5. Smithells R. W., Sheppard S., Schorah C. J. Vitamin deficiencies and neural tube defects. Arch Dis Child. 1976 Dec;51(12):944–950. doi: 10.1136/adc.51.12.944. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. THIERSCH J. B. Therapeutic abortions with a folic acid antagonist, 4-aminopteroylglutamic acid (4-amino P.G.A) administered by the oral route. Am J Obstet Gynecol. 1952 Jun;63(6):1298–1304. doi: 10.1016/s0002-9378(16)38924-4. [DOI] [PubMed] [Google Scholar]
  7. Tennant G. B., Withey J. L. An assessment of work simplified procedures for the microbiological assay of serum vitamin B12 and serum folate. Med Lab Technol. 1972 Apr;29(2):171–181. [PubMed] [Google Scholar]

Articles from British Medical Journal (Clinical research ed.) are provided here courtesy of BMJ Publishing Group

RESOURCES